NEW YORK (GenomeWeb News) – The formation of the Kinomed Partnership was announced today to provide integrated services for protein kinase inhibitor discovery and development and other research.
The European partnership comprises Iota Pharmaceuticals, protein research firm KinaseDetect, and drug discovery firm SARomics Biostructures.